301 related articles for article (PubMed ID: 15579193)
1. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome in Cushing's syndrome.
Chanson P; Salenave S
Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
[TBL] [Abstract][Full Text] [Related]
8. [Cardiovascular diseases and lipid abnormalities in Cushing's syndrome].
Luton JP; Richard C; Laudat MH; Pinon JC; Bricaire H
Nouv Presse Med; 1982 Sep; 11(36):2693-8. PubMed ID: 7145656
[TBL] [Abstract][Full Text] [Related]
9. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
[TBL] [Abstract][Full Text] [Related]
10. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
12. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines.
Bianchi ME; Farías EF; Bolaño J; Massari PU
Ren Fail; 2006; 28(8):665-70. PubMed ID: 17162424
[TBL] [Abstract][Full Text] [Related]
14. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
[TBL] [Abstract][Full Text] [Related]
15. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
16. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
[TBL] [Abstract][Full Text] [Related]
17. Effect of Cushing's syndrome - Endogenous hypercortisolemia on cardiovascular autonomic functions.
Jyotsna VP; Naseer A; Sreenivas V; Gupta N; Deepak KK
Auton Neurosci; 2011 Feb; 160(1-2):99-102. PubMed ID: 21177144
[TBL] [Abstract][Full Text] [Related]
18. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
de Simone G; Wachtell K; Palmieri V; Hille DA; Beevers G; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Julius S; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Devereux RB
Circulation; 2005 Apr; 111(15):1924-31. PubMed ID: 15837945
[TBL] [Abstract][Full Text] [Related]
19. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
[TBL] [Abstract][Full Text] [Related]
20. Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
Smebye ML; Iversen EK; Høieggen A; Flaa A; Os I; Kjeldsen SE; Olsen MH; Chattopadhyay A; Hille DA; Lyle PA; Devereux RB; Dahlöf B
Am J Cardiol; 2007 Sep; 100(5):855-9. PubMed ID: 17719333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
